Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison C Ross

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Antiviral Therapy|June 21, 2011
Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individualsAllison C Ross, Suzanne Judd, Meena Kumari, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 8, 2008
Endothelial activation markers are linked to HIV status and are independent of antiretroviral therapy and lipoatrophyAllison C Ross, Rachel Armentrout, Mary Ann O'Riordan, et al.
AIDS (London, England)|May 11, 2010
Rosiglitazone improves lipoatrophy in patients receiving thymidine-sparing regimensMarisa Tungsiripat, Dalia El Bejjani, Nesrine Rizk, et al.
HIV Clinical Trials|May 14, 2008
Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapyGrace A McComsey, Minhee Kang, Allison C Ross, et al.
Antiviral Therapy|June 25, 2008
Cord blood lipids in infants born to HIV-1-infected women treated with combination antiretroviral therapyAnn J Melvin, Minhee Kang, Jane Hitti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2009
Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapyAllison C Ross, Nesrine Rizk, Mary Ann O'Riordan, et al.
AIDS Research and Human Retroviruses|October 26, 2010
Carotid intima media thickness, inflammatory markers, and endothelial activation markers in HIV Patients with lipoatrophy increased at 48 weeks regardless of use of rosiglitazone or placeboMarisa Tungsiripat, Dalia El-Bejjani, Nesrine Rizk, et al.
Journal of AIDS & Clinical Research|December 11, 2012
Changes in Inflammation, Oxidative Stress, Mitochondrial DNA Content after Rosiglitazone in HIV LipoatrophyMarisa Tungsiripat, Dalia El-Bejjani, Nesrine Rizk, et al.
Antiviral Therapy|February 2, 2012
Vitamin D supplementation and endothelial function in vitamin D deficient HIV-infected patients: a randomized placebo-controlled trialChris T Longenecker, Corrilynn O Hileman, Teresa L Carman, et al.
The Journal of Infectious Diseases|July 18, 2012
Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinationsSharon E Frey, David I Bernstein, Michael A Gerber, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Antiviral Therapy|June 21, 2011
Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individualsAllison C Ross, Suzanne Judd, Meena Kumari, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 8, 2008
Endothelial activation markers are linked to HIV status and are independent of antiretroviral therapy and lipoatrophyAllison C Ross, Rachel Armentrout, Mary Ann O'Riordan, et al.
AIDS (London, England)|May 11, 2010
Rosiglitazone improves lipoatrophy in patients receiving thymidine-sparing regimensMarisa Tungsiripat, Dalia El Bejjani, Nesrine Rizk, et al.
HIV Clinical Trials|May 14, 2008
Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapyGrace A McComsey, Minhee Kang, Allison C Ross, et al.
Antiviral Therapy|June 25, 2008
Cord blood lipids in infants born to HIV-1-infected women treated with combination antiretroviral therapyAnn J Melvin, Minhee Kang, Jane Hitti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2009
Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapyAllison C Ross, Nesrine Rizk, Mary Ann O'Riordan, et al.
AIDS Research and Human Retroviruses|October 26, 2010
Carotid intima media thickness, inflammatory markers, and endothelial activation markers in HIV Patients with lipoatrophy increased at 48 weeks regardless of use of rosiglitazone or placeboMarisa Tungsiripat, Dalia El-Bejjani, Nesrine Rizk, et al.
Journal of AIDS & Clinical Research|December 11, 2012
Changes in Inflammation, Oxidative Stress, Mitochondrial DNA Content after Rosiglitazone in HIV LipoatrophyMarisa Tungsiripat, Dalia El-Bejjani, Nesrine Rizk, et al.
Antiviral Therapy|February 2, 2012
Vitamin D supplementation and endothelial function in vitamin D deficient HIV-infected patients: a randomized placebo-controlled trialChris T Longenecker, Corrilynn O Hileman, Teresa L Carman, et al.
The Journal of Infectious Diseases|July 18, 2012
Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinationsSharon E Frey, David I Bernstein, Michael A Gerber, et al.
Pageof 2